198 results on '"Carnovale, Vincenzo"'
Search Results
2. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
3. Lipidomic alterations in human saliva from cystic fibrosis patients
4. Clinical outcomes of digital health in adults with cystic fibrosis
5. Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype
6. Oxylipin profile in saliva from patients with cystic fibrosis reveals a balance between pro-resolving and pro-inflammatory molecules
7. The impact of cystic fibrosis on the working life of patients: A systematic review
8. Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation
9. Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del/minimal function genotype
10. Lumacaftor/ivacaftor improves liver cholesterol metabolism but does not influence hypocholesterolemia in patients with cystic fibrosis
11. Cystic Fibrosis in Adults: A Paradigm of Frailty Syndrome? An Observational Study
12. One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes
13. Economic impact using a virtual model of care in Cystic Fibrosis
14. Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study
15. TAS2R38 is a novel modifier gene in patients with cystic fibrosis
16. Clinical outcome of individuals carrying 5T;TG12 in trans with CFTR variants with varying clinical consequences
17. Clinical expression of patients with the D1152H CFTR mutation
18. Cystic Fibrosis Patients with F508del/Minimal Function Genotype: Laboratory and Nutritional Evaluations after One Year of Elexacaftor/Tezacaftor/Ivacaftor Treatment
19. Clinical outcome of individuals carrying 5T;TG12 in trans with CFTR variants with varying clinical consequences
20. Elexacaftor/tezacaftor/ivacaftor for CFTR variants giving rise to diagnostic uncertainty: Personalised medicine or over-medicalisation?
21. Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation and Advanced Lung Disease: A 48-Week Observational Study
22. Employment Status and Work Ability in Adults with Cystic Fibrosis
23. Assessment of NuvoAir platform use on clinical outcomes in adults with cystic fibrosis: a first Italian experience
24. Disease characterization of people with cystic fibrosis and a minimal function mutation: Data from the Italian registry
25. Use of dornase alfa in cystic fibrosis: an Audit of Italian specialists
26. Use of mucoactive agents in cystic fibrosis: A consensus survey of Italian specialists.
27. Physical Activity Regulates TNFα and IL-6 Expression to Counteract Inflammation in Cystic Fibrosis Patients
28. Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
29. Abstracts from the 23rd Italian congress of Cystic Fibrosis and the 13th National congress of Cystic Fibrosis Italian Society
30. The Diagnosis of Cystic Fibrosis in Adult Age. Data from the Italian Registry
31. Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study
32. Extensive CFTR Gene Analysis Revealed a Higher Occurrence of Cystic Fibrosis Transmembrane Regulator-Related Disorders (CFTR-RD) among CF Carriers
33. Cystic fibrosis with non‐G551D gating mutations in Italy: Epidemiology and clinical characteristics
34. Impaired Ratio of Unsaturated to Saturated Non-Esterified Fatty Acids in Saliva from Patients with Cystic Fibrosis
35. Salivary Cytokines and Airways Disease Severity in Patients with Cystic Fibrosis
36. Influence of pancreatic status on circulating plasma sterols in patients with cystic fibrosis
37. Factors increasing the risk for stone formation in adult patients with cystic fibrosis
38. Registro Italiano Fibrosi cistica Rapporto 2011-2014
39. Supervised physical exercise improves clinical, anthropometric and biochemical parameters in adult cystic fibrosis patients: a three years evaluation
40. Adiponectin Expression Is Modulated by Long-Term Physical Activity in Adult Patients Affected by Cystic Fibrosis
41. Cystic Fibrosis: The Sense of Smell
42. Effectivenesss of ivacaftor in severe cystic fibrosis patients and non‐G551D gating mutations
43. Clinical expression of cystic fibrosis in a large cohort of Italian siblings
44. Microbiology of airway disease in a cohort of patients with Cystic Fibrosis
45. Cystic fibrosis with non‐G551D gating mutations in Italy: Epidemiology and clinical characteristics.
46. Additional file 3: of Lung structure and function similarities between primary ciliary dyskinesia and mild cystic fibrosis: a pilot study
47. Additional file 1: of Lung structure and function similarities between primary ciliary dyskinesia and mild cystic fibrosis: a pilot study
48. Additional file 2: of Lung structure and function similarities between primary ciliary dyskinesia and mild cystic fibrosis: a pilot study
49. Cystic Fibrosis: The Sense of Smell.
50. Supervised physical exercise improves clinical, anthropometric and biochemical parameters in adult cystic fibrosis patients: A 2‐year evaluation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.